Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1590/1413-785220172503164827

http://scihub22266oqcxt.onion/10.1590/1413-785220172503164827
suck pdf from google scholar
C5474406!5474406!28642664
unlimited free pdf from europmc28642664    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid28642664      Acta+Ortop+Bras 2017 ; 25 (3): 71-3
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Surgical treatment results for dupuytren s disease #MMPMID28642664
  • Aykut S; Baydar M; Büyük AF; Öztürk ?A; Özden E; Öztürk K
  • Acta Ortop Bras 2017[May]; 25 (3): 71-3 PMID28642664show ga
  • OBJECTIVE:: To present the results of our cases of Dupuytren's disease treated with regional selective fasciectomy in light of the literature. METHODS:: Patients diagnosed with Dupuytren's contracture and surgically treated with regional selective fasciectomy at our institution with adequate follow-up data were included in the study. All patients were routinely followed after surgery to assess results and complications. QuickDASH scoring was used to evaluate the patients and recurrences and complications were recorded. RESULTS:: Twenty-one hands of 19 patients (13 males, 6 females) who underwent surgery and received adequate follow-up were retrospectively evaluated. Mean patient age was 65.8 (range: 41 to 86) and the mean follow-up period was 48.2 months (range: 24 to 86). Fourteen (66.6%) hands had excellent results, five (23%) hands had good results and two (9.4%) had fair results. The mean QuickDASH score for the patients at the final follow-up was 6.58 (range: 0 to 20.4). CONCLUSION:: Our study results demonstrated that regional selective fasciectomy is a reliable and efficient method to treat Dupuytren's disease with low rates of complications and recurrence and the technique can be considered the gold standard. Level of Evidence IV, Case Series.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box